Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non-Small-Cell Lung Cancer (NSCLC)

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 2, 2008, Pages 335-342

  Belderbos, José S A ^a   Kepka, Lucyna ^b   Martel, Mary K ^d   Videtic, Gregory M M ^e   Jeremic, Branislav ^f  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Spring) Kong, Feng Ming   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Elective nodal irradiation; Involved field irradiation; Isolated nodal failure; Non small cell lung cancer

Indexed keywords

IRRADIATION; PATIENT TREATMENT; RISK ASSESSMENT; TUMORS;

ELECTIVE NODAL IRRADIATION; INVOLVED-FIELD IRRADIATION; ISOLATED NODAL FAILURE; NON-SMALL-CELL LUNG CANCER; RADIOTHERAPY PLANNING; SMALL-CELL LUNG CANCER;

BIOLOGICAL ORGANS; IRRADIATION;

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; NUCLEAR ENERGY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME; CANCER CHEMOTHERAPY; CANCER RELAPSE; CLINICAL TRIAL; LOBECTOMY; LUNG CANCER; LUNG SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; PLEURA EFFUSION; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; INTERNATIONAL AGENCIES; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MEDIASTINUM; NEOPLASM STAGING; NUCLEAR ENERGY; RADIOTHERAPY DOSAGE; CARCINOMA, SMALL CELL; CLINICAL TRIALS AS TOPIC; POSITRON-EMISSION TOMOGRAPHY; TUMOR BURDEN;

EID: 51449108879     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.081     Document Type: Article

References (93)

1. Delaney G., Barton M., Jacob S., et al. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 4 (2003) 120-128
2. Tyldesley S., Boyd C., Schulze K., et al. Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys 49 (2001) 973-985
3. Kong F.M., Gaspar L.E., Komaki R., et al. Patterns of practice in radiation dose prescription and treatment planning for patients with lung cancer among members of American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 69 (2007) S483
4. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
5. Bradley J.D., Wahab S., Lockett M.A., et al. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56 (2003) 342-347
6. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
7. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
8. Zhao L., West B.T., Hayman J.A., et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 103-110
9. Machtay M., Swann S., Komaki R., et al. Higher BED is associated with improved local-regional control and survival for NSCLC treated with chemoradiotherapy: An RTOG Analysis. Int J Radiat Oncol Biol Phys 63 (2005) S40
10. Rengan R., Rosenzweig K.E., Venkatraman E., et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 741-747
11. Wang L., Zhao L., Correa C., et al. Radiation dose is an independent predictor for overall survival in patients with stage III unresectable non-small cell lung cancer treated by radiation with and without chemotherapy. Int J Radiat Oncol Biol Phys 69 (2007) S59
12. Yuan S., Sun X., Li M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
13. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
14. Martel M.K., Sahijdak W.M., Hayman J.A., et al. Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 45 (1999) S244
15. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?. Radiother Oncol 71 (2004) 123-125
16. Chen M., Hayman J.A., Ten Haken R.K., et al. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation?. Int J Radiat Oncol Biol Phys 64 (2006) 120-126
17. Chapet O., Haken R.K., Quint L., et al. Incidental irradiation to non-involved nodal stations in patients with Stage III non-small cell lung cancer treated with 3-D conformal radiation therapy. Int J Radiat Oncol Biol Phys 69 (2006) S474-S475
18. Chapet O., Kong F.M., Quint L.E., et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63 (2005) 170-178
19. Jeremic B. Low incidence of isolated nodal failures after involved-field radiation therapy for non small-cell lung cancer: Blinded by the light?. J Clin Oncol 25 (2007) 5543-5545
20. Chen Z.L., Perez S., Holmes E.C., et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85 (1993) 493-498
21. Passlick B., Izbicki J.R., Kubuschok B., et al. Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis. Ann Thorac Surg 61 (1996) 177-182
22. Dobashi K., Sugio K., Osaki T., et al. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: Prognostic significance. J Thorac Cardiovasc Surg 114 (1997) 339-346
23. Maruyama R., Sugio K., Mitsudomi T., et al. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 114 (1997) 535-543
24. Perez C.A., Stanley K., Grundy G., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group. Cancer 50 (1982) 1091-1099
25. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8 (1990) 1543-1555
26. Dillman R.O., Herndon J., Seagren S.L., et al. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
27. Arriagada R., Le Chevalier T., Quoix E., et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Federation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int J Radiat Oncol Biol Phys 20 (1991) 1183-1190
28. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
29. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 52 (1999) 137-148
30. Jeremic B., Milicic B., Acimovic L., et al. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: Long-term results of a phase II study. J Clin Oncol 23 (2005) 1144-1151
31. Rocmans P., Emami B., Cox J.D., et al. Quality control in NSCLC treatment: A consensus report. Lung Cancer 7 (1991) S19-S20
32. Emami B., Scott C., Byhardt R., et al. The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis. Int J Radiat Oncol Biol Phys 36 (1996) S209
33. Emami B., Mirkovic N., Scott C., et al. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: An analysis of RTOG data. Lung Cancer 41 (2003) 207-214
34. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 24 (1992) 3-9
35. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
36. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
37. Morita K., Fuwa N., Suzuki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients. Radiother Oncol 42 (1997) 31-36
38. Glazer G.M., Orringer M.B., Gross B.H., et al. The mediastinum in non-small cell lung cancer: CT-surgical correlation. AJR Am J Roentgenol 142 (1984) 1101-1105
39. Heavey L.R., Glazer G.M., Gross B.H., et al. The role of CT in staging radiographic T1N0M0 lung cancer. AJR Am J Roentgenol 146 (1986) 285-290
40. Conces Jr. D.J., Klink J.F., Tarver R.D., et al. T1N0M0 lung cancer: Evaluation with CT. Radiology 170 (1989) 643-646
41. Martini N., and Beattie Jr. E.J. Results of surgical treatment in Stage I lung cancer. J Thorac Cardiovasc Surg 74 (1977) 499-505
42. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
43. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995) 615-622
44. Koike T., Terashima M., Takizawa T., et al. Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 115 (1998) 1015-1020
45. Wu J., Ohta Y., Minato H., et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 71 (2001) 1772-1777
46. Sawyer T.E., Bonner J.A., Gould P.M., et al. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: Implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys 43 (1999) 965-970
47. Suzuki K., Nagai K., Yoshida J., et al. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 72 (2001) 352-356
48. Suzuki K., Nagai K., Yoshida J., et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117 (1999) 593-598
49. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
50. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: A meta-analysis. Ann Intern Med 139 (2003) 879-892
51. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA 285 (2001) 914-924
52. Annema J.T., Versteegh M.I., Veselic M., et al. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol 23 (2005) 8357-8361
53. de Langen A.J., Raijmakers P., Riphagen I., et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: A meta-analysis. Eur J Cardiothorac Surg 29 (2006) 26-29
54. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
55. Erdi Y.E., Rosenzweig K., Erdi A.K., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
56. Steenbakkers R.J.H.M., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
57. Mah K., Caldwell C.B., Ung Y.C., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
58. Zhao L., Chen M., Ten Haken R., et al. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located. Radiother Oncol 82 (2007) 153-159
59. Schwarz M., Alber M., Lebesque J.V., et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) 561-570
60. Zhang H.X., Yin W.B., Zhang L.J., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14 (1989) 89-94
61. Talton B.M., Constable W.C., and Kersh C.R. Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 19 (1990) 15-21
62. Hayakawa K., Mitsuhashi N., Nakajima N., et al. Radiation therapy for stage I-III epidermoid carcinoma of the lung. Lung Cancer 8 (1992) 213-223
63. Slotman B.J., Antonisse I.E., and Njo K.H. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 41 (1996) 41-44
64. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26 (1999) 137-142
65. Wolthaus J.W., Schneider C., Sonke J.J., et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 65 (2006) 1560-1571
66. Morrison R., Delley T.J., and Cleland W.P. The treatment of carcinoma of the bronchus. A clinical trial to compare surgery and supervoltage radiotherapy. Lancet 7283 (1963) 683-684
67. Haffty B.G., Goldberg N.B., Gerstley J., et al. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15 (1988) 69-73
68. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
69. Jeremic B., Shibamoto Y., Stanisavljevic B., et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol 43 (1997) 29-37
70. Jeremic B., Shibamoto Y., Acimovic L., et al. Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer. Radiother Oncol 51 (1999) 141-145
71. Rosenzweig K.E., Sura S., Jackson A., et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25 (2007) 5557-5561
72. Belderbos J.S.A., Boersma J.L., and Lebesque J.V. Elective nodal irradiation in non-small cell lung cancer. In: Mornex F., and van Houtte P. (Eds). Treatment optimization for lung cancer from classical to innovative procedures-IASLC International Workshop, 24-26 June, 1998 (1998), Elsevier, Amsterdam 99-102
73. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
74. Fu X.L., Jiang G.L., Wang L.J., et al. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: Clinical phase I/II trial. Int J Radiat Oncol Biol Phys 39 (1997) 545-552
75. Fang L.C., Komaki R., Allen P., et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 108-116
76. Rowell N.P., and Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev (2001) CD002935
77. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 19 (2001) 127-136
78. Rosenzweig K.E., Sim S.E., Mychalczak B., et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
79. Kepka L., Bujko K., and Zolciak-Siwinska A. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques. Acta Oncol 47 (2008) 95-103
80. De Ruysscher D., Bremer R.H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial. Radiother Oncol 80 (2006) 307-312
81. Jeremic B., Classen J., and Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
82. Williams T.E., Thomas Jr. C.R., and Turrisi A.T. III. Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 10 (2000) 315-323
83. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
84. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
85. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
86. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
87. International Commission on Radiation Units and Measurements. ICRU Report 62. Prescribing, recording and reporting photon beam therapy. (Supplement to ICRU Report 50) (1999), ICRU, Bethesda, MD
88. Giraud P., De Rycke Y., Lavole A., et al. Probability of mediastinal involvement in non-small-cell lung cancer: A statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?. Int J Radiat Oncol Biol Phys 64 (2006) 127-135
89. Senan S., De Ruysscher D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
90. National Collaborating Centre for Acute Care at the Royal College of Surgeons of England. The diagnosis and treatment of lung cancer. CG24 lung cancer full guideline. Available online at: http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdf. 2005. Accessed June 19, 2008.
91. Scottish Intercollegiate Guidelines Network. Management of patients with lung cancer. Available online at: http://www.sign.ac.uk/pdf/qrg80.pdf. 2005. Accessed June 19, 2008.
92. Casas F., Vinolas N., Sanchez-Reyes A., et al. Spanish patterns of care for 3D radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 138-142
93. Kepka L., Danilova V., Saghatelyan T., et al. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: Results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer 56 (2007) 235-245